UT Southwestern NCI National Clinical Trials Network (NCTN) LAPS - Supplemental Funds YR4

UT 西南 NCI 国家临床试验网络 (NCTN) LAPS - 补充资金 YR4

基本信息

  • 批准号:
    10733732
  • 负责人:
  • 金额:
    $ 4.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-05-22 至 2023-02-28
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT (from UG1CA233302 parent award) For years, the University of Texas Southwestern Medical Center (UTSW) has provided key leadership within the National Clinical Trials Network (NCTN). The leaders of this UG1 application and other faculty members hold major NCTN roles, including chairing clinical trials and committees. From March 2014 through August 2017, UTSW enrolled 520 patients on adult NCTN trials across 13 disease categories. During that time, UTSW faculty authored or co-authored 27 publications directly related to NCTN trials, and have chaired, co-chaired, or served as cooperative group committee chairs on 13 cooperative group trials. Substantial recent growth positions UTSW to expand accrual and scientific contributions. After receiving initial NCI designation in 2010, the Harold C. Simmons Cancer Center received comprehensive designation in 2015. Since 2015, two new hospitals affiliated with UTSW have been constructed. We have a vibrant drug discovery program; SPORE grants in lung cancer and kidney cancer; an Advanced Imaging Research Center; and a Patient Centered Outcomes Research (PCOR) Center. As the only academic medical center and medical school in the Dallas/Ft. Worth (DFW) Metroplex (population 7.2 million) and the only NCI-designated Comprehensive Cancer Center in North Texas, UTSW reaches a large and diverse population that otherwise would not have access to NCTN trials. In recent years, up to 29% of our patients enrolled on NCTN clinical studies were Hispanic, and up to 21% were African American. The specific aims of the UTSW UG1 are the following: Aim 1. Contribute to NCTN trial accrual. We will continue to enroll patients with diverse ethnic and racial backgrounds on therapeutic and non-therapeutic trials. Aim 2. Contribute to NCTN scientific direction. We will bring UTSW basic, translational, and imaging research into hypothesis-driven clinical trials. Aim 3. Provide NCTN leadership. UTSW faculty will continue to chair and co-chair clinical trials and committees in the various NCTN groups, and by participate in NCI activities and initiatives. Aim 4. Promote career development of junior faculty and trainees. UTSW faculty will provide mentoring and guidance in the NCTN. Aim 5. Support NCTN administrative efforts. UTSW faculty will continue to serve on NCTN and NCI regulatory and auditing committees. At multiple steps, the design and conduct of cancer clinical research has become more challenging. Financial pressures have limited the protected time of clinical investigators nationwide. Increasing cost and complexity of clinical trials has prolonged activation timelines and restricted eligibility. UTSW is poised to meet and overcome these challenges. With designated funding and mentoring programs, we continue to develop clinical investigators and disease experts. We have capitalized on a large and diverse patient base, as well as growing bioinformatics capabilities, to optimize the identification, screening, and enrollment of clinical trial subjects. Together, these approaches position UTSW to continue to help lead and expand NCTN efforts.
项目摘要/摘要(来自UG1CA233302家长奖)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Eric Gerber其他文献

David Eric Gerber的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Eric Gerber', 18)}}的其他基金

Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
  • 批准号:
    10630125
  • 财政年份:
    2020
  • 资助金额:
    $ 4.53万
  • 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
  • 批准号:
    10418693
  • 财政年份:
    2020
  • 资助金额:
    $ 4.53万
  • 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
  • 批准号:
    9921601
  • 财政年份:
    2020
  • 资助金额:
    $ 4.53万
  • 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
  • 批准号:
    10376977
  • 财政年份:
    2020
  • 资助金额:
    $ 4.53万
  • 项目类别:
Finding the optimal balance of immunotherapy efficacy and toxicity.
寻找免疫治疗功效和毒性的最佳平衡。
  • 批准号:
    10189523
  • 财政年份:
    2020
  • 资助金额:
    $ 4.53万
  • 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
UT 西南 NCI 国家临床试验网络领先学术网站
  • 批准号:
    10359155
  • 财政年份:
    2019
  • 资助金额:
    $ 4.53万
  • 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
UT 西南 NCI 国家临床试验网络领先学术网站
  • 批准号:
    10062108
  • 财政年份:
    2019
  • 资助金额:
    $ 4.53万
  • 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site
UT 西南 NCI 国家临床试验网络领先学术网站
  • 批准号:
    10581694
  • 财政年份:
    2019
  • 资助金额:
    $ 4.53万
  • 项目类别:
Evaluating prior cancer exclusion policy to increase lung cancer trial accrual
评估先前的癌症排除政策以增加肺癌试验的应计数量
  • 批准号:
    9108931
  • 财政年份:
    2015
  • 资助金额:
    $ 4.53万
  • 项目类别:
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
UT 西南 NCI 国家临床试验网络主要学术网站 - U10
  • 批准号:
    9248972
  • 财政年份:
    2014
  • 资助金额:
    $ 4.53万
  • 项目类别:

相似海外基金

A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
  • 批准号:
    10509308
  • 财政年份:
    2022
  • 资助金额:
    $ 4.53万
  • 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
  • 批准号:
    10680412
  • 财政年份:
    2022
  • 资助金额:
    $ 4.53万
  • 项目类别:
Understanding social undermining of weight management behaviors in young adult African American women
了解年轻非洲裔美国女性体重管理行为的社会破坏
  • 批准号:
    10535890
  • 财政年份:
    2022
  • 资助金额:
    $ 4.53万
  • 项目类别:
A neuroimaging approach to advance mechanistic understanding of tobacco use escalation risk among young adult African American vapers
一种神经影像学方法,可促进对年轻非洲裔美国电子烟使用者烟草使用升级风险的机制理解
  • 批准号:
    10629374
  • 财政年份:
    2022
  • 资助金额:
    $ 4.53万
  • 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
  • 批准号:
    10553725
  • 财政年份:
    2021
  • 资助金额:
    $ 4.53万
  • 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
  • 批准号:
    10494191
  • 财政年份:
    2021
  • 资助金额:
    $ 4.53万
  • 项目类别:
Impact of Adult Day Services on Psychosocial and Physiological Measures of Stress among African American Dementia Family Caregivers
成人日间服务对非裔美国痴呆症家庭护理人员的社会心理和生理压力测量的影响
  • 批准号:
    10328955
  • 财政年份:
    2021
  • 资助金额:
    $ 4.53万
  • 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
  • 批准号:
    10437374
  • 财政年份:
    2021
  • 资助金额:
    $ 4.53万
  • 项目类别:
Voice-Activated Technology to Improve Mobility & Reduce Health Disparities: EngAGEing African American Older Adult-Care Partner Dyads
语音激活技术可提高移动性
  • 批准号:
    10654831
  • 财政年份:
    2021
  • 资助金额:
    $ 4.53万
  • 项目类别:
Development, Implementation, and Evaluation of a Smoking Cessation Intervention Tailored to Rural Young Adult African American Men: Toward Scalability
针对农村年轻非裔美国男性的戒烟干预措施的制定、实施和评估:走向可扩展性
  • 批准号:
    9896786
  • 财政年份:
    2018
  • 资助金额:
    $ 4.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了